SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-195429
Filing Date
2024-08-07
Accepted
2024-08-07 07:49:01
Documents
21
Period of Report
2024-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d832401d8k.htm   iXBRL 8-K 46947
2 EX-10.1 d832401dex101.htm EX-10.1 17763
3 EX-10.2 d832401dex102.htm EX-10.2 63321
4 EX-10.3 d832401dex103.htm EX-10.3 34201
5 EX-10.4 d832401dex104.htm EX-10.4 30067
6 EX-10.5 d832401dex105.htm EX-10.5 38234
7 EX-99.1 d832401dex991.htm EX-99.1 106066
8 EX-99.2 d832401dex992.htm EX-99.2 5605
12 GRAPHIC g832401snap1.jpg GRAPHIC 5230
  Complete submission text file 0001193125-24-195429.txt   555050

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA itci-20240802.xsd EX-101.SCH 2895
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20240802_lab.xml EX-101.LAB 17235
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20240802_pre.xml EX-101.PRE 10842
23 EXTRACTED XBRL INSTANCE DOCUMENT d832401d8k_htm.xml XML 3481
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 241181480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)